National Vaccine Program Office, Office of the Assistant Secretary for Health, US Department of Health and Human Services, Washington, D.C., United States.
Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vaccine. 2019 Feb 28;37(10):1277-1283. doi: 10.1016/j.vaccine.2019.01.044. Epub 2019 Feb 6.
Despite recommendations for vaccinating adults and widespread availability of immunization services (e.g., pharmacy venues, workplace wellness clinics), vaccination rates in the United States remain low. The U.S. National Adult Immunization Plan identified the development of quality measures as a priority and key strategy to address low adult vaccination coverage rates. The use of quality measures can provide incentives for increased utilization of preventive services. To address the lack of adult immunization measures, the National Adult and Influenza Immunization Summit, a coalition of adult immunization partners led by the Immunization Action Coalition, Centers for Disease Control and Prevention, and National Vaccine Program Office, spearheaded efforts to (1) identify gaps and priorities in adult immunization quality performance measurement; (2) explore feasibility of data collection on adult immunizations through pilot testing and engaging stakeholders; and (3) develop and test quality measure specifications. This paper outlines the process by which a public-private partnership drove the development of two adult immunization performance measures-an adult immunization status measure for influenza, tetanus and diphtheria (Td) and/or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap), herpes zoster and pneumococcal vaccines, and a prenatal immunization status measure for influenza and Tdap vaccinations in pregnant women. These measures have recently been added to the 2019 Healthcare Effectiveness Data and Information Set (HEDIS®), a widely used set of performance measures reportable by private health plans.
尽管有建议为成年人接种疫苗，并且免疫接种服务广泛可用（例如，药房场所，工作场所健康诊所），但美国的疫苗接种率仍然很低。美国国家成人免疫计划确定制定质量措施是解决成年人疫苗接种覆盖率低的优先事项和关键策略。使用质量措施可以为增加预防服务的利用提供激励。为了解决成人免疫措施不足的问题，由免疫行动联盟、疾病预防控制中心和国家疫苗计划办公室领导的成人免疫合作伙伴组成的国家成人和流感免疫峰会牵头努力：（1）确定成人免疫质量绩效衡量方面的差距和优先事项；（2）通过试点测试和吸引利益相关者，探索成人免疫数据收集的可行性；（3）制定和测试质量衡量标准。本文概述了公私合作伙伴关系推动制定两项成人免疫绩效衡量标准的过程：针对流感、破伤风和白喉（Td）和/或破伤风类毒素、白喉减毒活疫苗和无细胞百日咳（Tdap）、带状疱疹和肺炎球菌疫苗的成人免疫状况衡量标准，以及针对孕妇流感和 Tdap 疫苗接种的产前免疫状况衡量标准。这些措施最近已被添加到 2019 年医疗保健效果数据和信息集（HEDIS®）中，这是一个广泛使用的私人健康计划可报告的绩效衡量标准集。
